Carbonyl Reductase 1 (CBR1) is a ubiquitously expressed cytosolic enzyme that plays a pivotal role in the metabolism of both xenobiotic and endogenous carbonyl compounds. Its catalytic activity is ...
This article is based on a poster originally authored by Daniel A. Barr, Mario Öeren, Peter A. Hunt, Jonathan D. Tyzack, Tomáš Chrien, Tamsin E. Mansley and Matthew D. Segall, which was presented at ...
The application of pharmacogenetics in identifying single nucleotide polymorphisms (SNPs) in DNA sequences that cause clinically significant alterations in drug-metabolizing enzyme activities is ...
Pharmacogenetics and pharmacogenomics are increasingly recognised as playing a pivotal role in the advancement of personalised medicine, especially in the ...
A new combination of existing drugs reduces the size of cancerous tumors much more effectively than current treatments. A new drug lead shows promise that it could reduce the size of cancerous tumors ...
A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...
The Brighterside of News on MSN
Breakthrough new drug lowers blood sugar and burns fat without muscle loss
A new study offers fresh hope for people living with type 2 diabetes and obesity. Researchers report progress toward a pill ...
After a century of false starts, scientists believe they have found a way to make cells burn more energy without the ...
Among the many ways neuroscientists think Alzheimer’s disease may strip away brain function is by disrupting the glucose metabolism needed to fuel the healthy brain. In essence, declining metabolism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback